SciClone Pharmaceuticals Updates Share Options

SciClone Pharmaceuticals (Holdings) Limited (HK:6600) has released an update.

SciClone Pharmaceuticals (Holdings) Limited has announced the exercise of 20,000 Share Options under its Post-IPO Option Plan, resulting in the issuance of the same number of new shares. Following this, the company has a total of 630,237,132 shares in issue and 66,546,932 Share Options outstanding across various plans. This action is part of the ongoing processes detailed in the company’s recent announcements and adherence to the Hong Kong Code on Takeovers and Mergers.

For further insights into HK:6600 stock, check out TipRanks’ Stock Analysis page.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.